Welcome to our dedicated page for Stryker news (Ticker: SYK), a resource for investors and traders seeking the latest updates and insights on Stryker stock.
Stryker Corporation (NYSE: SYK) is a global innovator in medical technologies, driving advancements in orthopedics, surgical equipment, and digital healthcare solutions. This dedicated news hub provides investors and healthcare professionals with essential updates on SYK's latest developments, financial performance, and strategic initiatives.
Access authoritative information on earnings announcements, product innovations, regulatory milestones, and acquisition activity. Our curated collection ensures timely access to press releases covering SYK's neurotechnology systems, AI-assisted surgical tools, and minimally invasive treatment solutions that shape modern healthcare.
Key updates include quarterly financial results, FDA clearances for medical devices, partnership announcements, and insights into SYK's expanding digital health ecosystem. Stay informed about developments in robotic-assisted surgery platforms, smart operating room integrations, and global market expansion efforts.
Bookmark this page for streamlined access to verified SYK updates. Check regularly for objective reporting on how Stryker's innovations in joint replacement technologies, emergency care equipment, and healthcare IT solutions continue impacting patient outcomes worldwide.
Stryker has partnered with IRCAD North America, part of Atrium Health, to create an advanced surgical training center in Charlotte, NC. As part of a multi-year agreement, Stryker will supply cutting-edge medical devices and technologies to the center. Scheduled to open in summer 2025, IRCAD NA will serve as a hub for medical professionals worldwide. The center will leverage robotics, virtual and augmented reality, and artificial intelligence for surgical training. The collaboration aims to enhance medical education and patient care, aligning with Stryker’s mission to improve healthcare. The Pearl, an innovation district where IRCAD NA will be located, will also feature a new campus of Wake Forest University School of Medicine, fostering further advancements in medical science.
Stryker (NYSE:SYK) has launched the LIFEPAK 35, an advanced monitor/defibrillator aimed at supporting emergency responders and healthcare professionals. Unveiled on June 4, 2024, the device is designed to reduce caregiver burden and streamline workflow. It features a modern, intuitive platform, a slim and ergonomic design, and a large touch screen for a customizable clinical experience. The LIFEPAK 35 enables real-time access to important patient information, thereby enhancing patient care. It also offers trend monitoring and configurable events, aiding in clinical decision-making. The device is the result of over ten years of research and feedback from global customers.
Stryker (NYSE: SYK), a leader in medical technologies, has signed a definitive agreement to acquire Artelon, a company specializing in soft tissue fixation products. This acquisition aims to enhance Stryker's offerings in foot and ankle and sports medicine procedures, complementing its existing product range. Artelon's synthetic technology, designed for ligament and tendon reconstruction, has seen over 60,000 implantations worldwide. This move positions Stryker competitively in the segment, promising innovative biomaterial technology that aids soft tissue healing. The deal is subject to customary closing conditions, with both companies operating separately until then.
Stryker (NYSE:SYK) has completed the first European surgeries using its Gamma4 Hip Fracture Nailing System in Switzerland and France. The system, which treats hip and femur fractures, uses a design based on Stryker's extensive SOMA database. After obtaining CE certification in November 2023, it has been used in over 25,000 cases in North America and Japan.
Following the European debut, over 35 additional surgeries have been completed across several countries. A live broadcast event on June 4, 2024, in Germany will feature insights and case discussions led by esteemed faculty from across Europe.
Stryker (NYSE:SYK) has declared a $0.80 per share quarterly dividend payable on July 31, 2024, to shareholders of record on June 28, 2024. This represents a 6.7% increase from the prior year.
Stryker (NYSE: SYK) successfully completed the first European surgeries using the Infinity Total Ankle System with Adaptis and Everlast technology. The system is designed for efficient and accurate implementation, with positive outcomes in end-stage ankle arthritis patients. The company aims to enhance collaboration with surgeons through innovation and commitment to research.
Stryker reported strong operating results for the first quarter of 2024, with a 9.7% increase in net sales to $5.2 billion, 10% organic net sales growth, and a 33.1% increase in reported EPS. The company's MedSurg and Neurotechnology segment saw a 11.5% increase in net sales, while Orthopaedics and Spine segment reported a 7.5% increase. Adjusted operating income margin increased to 21.9%, and adjusted EPS rose by 16.8%. Stryker expects full year 2024 organic net sales growth in the range of 8.5% to 9.5%, with adjusted net earnings per diluted share projected to be between $11.85 to $12.05.
FAQ
What is the current stock price of Stryker (SYK)?
What is the market cap of Stryker (SYK)?
